Global Next-Generation Sequencing on Drug Development Market

Report Code: BIO246A

Publish Date: Sep 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global next-generation sequencing (NGS) market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a compound annual growth rate (CAGR) of 17.7% for the forecast period of 2023 to 2028.

Report Includes

  • 52 data tables and 39 additional tables
  • An overview of the global markets for next-generation sequencing on drug development
  • Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of next-generation sequencing on drug development market by product, service, end-user type, and region
  • Examination of the key drivers and constraints that will shape the market for next-generation sequencing on drug development and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and subsegments
  • Coverage of recent advances, emerging technologies, and developments of the industry
  • Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
  • Profiles of the key companies of the industry, including 10x Genomics, Bio-Rad Laboratories Inc., Oxford Nanopore Technologies, Qiagen and Takara Bio Inc.

Report Scope

The scope of this report includes NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS in drug development are given for 2020, 2021, 2022, 2023 and 2028.

This report reviews the NGS technologies and explains why NGS is important in drug development. It then discusses some of the significant research initiatives that impact NGS. The main market-driving forces are also discussed.

This report examines the markets by product type, end user and region. This report provides market data and forecasts for NGS by product type, including instruments, consumables and services for drug development.

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the Rest of the World.

BCC Research summarizes the main industry acquisitions and strategic alliances from Jan. 2020, through Dec. 2022, including key alliance trends.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $1.1 billion
Market size forecast $2.9 billion
Growth rate CAGR of 17.7% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Product Type, End-User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
Key Market Drivers
  • Increasing R&D Activities using NGS technologies
  • Increase in Healthcare Expenditure
  • Technological Advancements in Sequencing Platforms
  • Shift Towards Precision Medicine
  • Growing demand of NGS for Designing Individualized Medicine to Cancer Patients
  • High Accuracy and Low Cost
Companies studied
10X GENOMICSAGILENT TECHNOLOGIES INC.
BGI (BEIJING GENOMICS INSTITUTE)BIO-RAD LABORATORIES INC.
CD GENOMICSILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.MICRONOMA
NEW ENGLAND BIOLABSOXFORD NANOPORE TECHNOLOGIES PLC.
PACBIOPERKINELMER INC.
PROMEGA CORP.PSOMAGEN INC.
Precision Medicine Group LLC.QIAGEN
F. HOFFMANN-LA ROCHE LTD.THERMO FISHER SCIENTIFIC INC.
TAKARA BIO INC.TECAN GROUP LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The next-generation sequencing on drug development market is projected to grow from $1.1 billion in 2022 to $2.9 billion in 2028 at a compound annual growth rate (CAGR) of 17.7% during the forecast period.
The key factors driving the growth of the next-generation sequencing on drug development market include increasing research and development activities utilizing NGS technologies, the rise in technological advancements, the shift towards precision medicine, and the Growing demand to NGS for designing individualized medicine for cancer patients is boosting the growth of the next-generation sequencing on the drug development market.
The next-generation sequencing on the drug development market is segmented based on product type, by end-user, and by region.
The consumables segment will dominate the next-generation sequencing on drug development market by the end of 2028.
Key companies in the market include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Oxford Nanopore Technologies plc., F Hoffmann-La Roche AG, Takara Bio, PacBio., Tecan Group, 10X Genomics, Bio-Rad Laboratories, Inc., PerkinElmer, BGI Genomics, Psomagen, Inc., Integrated DNA technologies, CD Genomics, New England Biolabs, and Promega Corp.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Next-Generation Sequencing on Drug Development Market177Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights5Free
Chapter- 3: Market Overview33Free
Chapter- 4: Market Dynamics8Free
Chapter- 5: NGS in Drug Development by Product Type8Free
Chapter- 6: NGS Market in Drug Development by End User4Free
Chapter- 7: NGS Market in Drug Development by Region11Free
Chapter- 8: Sustainability of NGS in Drug Development: An ESG Perspective10Free
Chapter- 9: Emerging Technologies and Developments3Free
Chapter- 10: Patent Analysis15Free
Chapter- 11: M&A and Funding Outlook3Free
Chapter- 12: Competitive Landscape3Free
Chapter- 13: Company Profiles68Free
Chapter- 14: Appendix: Acronyms1Free

Related Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - BIO126E

The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.

Next-Generation Cancer Diagnostics: Technologies and Global Markets

Published - Jun 2023 | Publisher - Kottapenta Sai Ratna Bramara Kalyani | Code - BIO081D

The global next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2022-2027.

Next Generation Sequencing for Non-invasive Prenatal Testing: Global Insights

Published - Sep 2018 | Publisher - BCC Publishing | Code - BIO173A

The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Next-Generation Sequencing on Drug Development Market
Sample Report